{"protocolSection": {"identificationModule": {"nctId": "NCT00530855", "orgStudyIdInfo": {"id": "SP0904"}, "secondaryIdInfos": [{"id": "2007-005440-25", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "UCB Pharma", "class": "INDUSTRY"}, "briefTitle": "Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures", "officialTitle": "A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects With Partial-onset Seizures"}, "statusModule": {"statusVerifiedDate": "2017-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": true, "nctId": "NCT03559673", "statusForNctId": "NO_LONGER_AVAILABLE"}, "startDateStruct": {"date": "2008-02"}, "primaryCompletionDateStruct": {"date": "2014-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-09-14", "studyFirstSubmitQcDate": "2007-09-14", "studyFirstPostDateStruct": {"date": "2007-09-18", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2015-05-18", "resultsFirstSubmitQcDate": "2015-05-18", "resultsFirstPostDateStruct": {"date": "2015-06-03", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2018-06-20", "lastUpdatePostDateStruct": {"date": "2018-07-18", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "UCB Pharma", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "This open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset seizures who were previously enrolled in the conversion to monotherapy trial (SP902)."}, "conditionsModule": {"conditions": ["Epilepsy"], "keywords": ["Epilepsy", "Partial-onset Seizures", "Lacosamide", "Monotherapy", "Vimpat"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 322, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Lacosamide", "type": "EXPERIMENTAL", "description": "Lacosamide tablets for dosing 100 -800 mg/day", "interventionNames": ["Drug: Lacosamide"]}], "interventions": [{"type": "DRUG", "name": "Lacosamide", "description": "50 mg and 100 mg Lacosamide tablets taken for 50 -400 mg twice daily dosing for up to 2 years", "armGroupLabels": ["Lacosamide"], "otherNames": ["Vimpat"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Percentage of Subjects on Lacosamide (LCM) Monotherapy at Any Time Between Visit 1 and End of Study", "description": "Percentage of Subjects on Lacosamide (LCM) Monotherapy at any time between Visit 1 and End of Study.", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)"}, {"measure": "Duration of Lacosamide (LCM) Monotherapy Treatment From Visit 1 to End of Study", "description": "Duration of total Lacosamide Monotherapy From Visit 1 to End of Study.", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)"}], "secondaryOutcomes": [{"measure": "Occurrence of At Least One Treatment-Emergent Adverse Event (TEAE) From Visit 1 to End of Study", "description": "A TEAE is defined as any untoward medical occurrence (eg, noxious or pathological changes) in a subject or clinical investigation subject compared with pre-existing conditions, that occurs during any phase of a clinical trial including Pretreatment, Run-In, Wash-Out, or Follow-Up Phases.\n\nAn TEAE is defined as being independent of assumption of any causality (eg, to trial or concomitant medication, primary or concomitant disease, or trial design).", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)"}, {"measure": "Occurrence of Treatment-Emergent Adverse Events (TEAE) Leading to Subject Withdrawal From Visit 1 to End of Study", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Subject has entered the Maintenance Phase of the double-blind trial, SP902, (ie, has taken at least 1 dose of SP902 Maintenance Phase trial medication) and either completed SP902 or met an exit criterion in SP902; subject is allowed up to 2 concomitant Antiepileptic Drugs (AEDs)\n\nExclusion Criteria:\n\n* Subject meets the withdrawal criteria (excluding exit criteria) for the SP902 trial, or is experiencing an ongoing Serious Adverse Event (SAE)", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "16 Years", "maximumAge": "70 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "UCB Clinical Trial Call Center", "affiliation": "+1 877 822 9493 (UCB)", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "048", "city": "Alabaster", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.24428, "lon": -86.81638}}, {"facility": "010", "city": "Birmingham", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "042", "city": "Northport", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.22901, "lon": -87.57723}}, {"facility": "009", "city": "Phoenix", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "014", "city": "Phoenix", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "151", "city": "Phoenix", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "103", "city": "Tucson", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"facility": "102", "city": "Jonesboro", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 35.8423, "lon": -90.70428}}, {"facility": "007", "city": "Little Rock", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "086", "city": "Little Rock", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "120", "city": "La Habra", "state": "California", "country": "United States", "geoPoint": {"lat": 33.93196, "lon": -117.94617}}, {"facility": "059", "city": "Los Angeles", "state": "California", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "021", "city": "Santa Monica", "state": "California", "country": "United States", "geoPoint": {"lat": 34.01945, "lon": -118.49119}}, {"facility": "107", "city": "Torrance", "state": "California", "country": "United States", "geoPoint": {"lat": 33.83585, "lon": -118.34063}}, {"facility": "060", "city": "Aurora", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.72943, "lon": -104.83192}}, {"facility": "025", "city": "Fairfield", "state": "Connecticut", "country": "United States", "geoPoint": {"lat": 41.14121, "lon": -73.26373}}, {"facility": "094", "city": "Doral", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.81954, "lon": -80.35533}}, {"facility": "108", "city": "Gainesville", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"facility": "123", "city": "Miami", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "132", "city": "Miami", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "077", "city": "Orlando", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "049", "city": "Panama City", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.15946, "lon": -85.65983}}, {"facility": "129", "city": "Port Charlotte", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.97617, "lon": -82.09064}}, {"facility": "050", "city": "Sarasota", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.33643, "lon": -82.53065}}, {"facility": "004", "city": "Tallahassee", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.43826, "lon": -84.28073}}, {"facility": "079", "city": "Atlanta", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "058", "city": "Boise", "state": "Idaho", "country": "United States", "geoPoint": {"lat": 43.6135, "lon": -116.20345}}, {"facility": "131", "city": "Hines", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 41.85364, "lon": -87.8395}}, {"facility": "146", "city": "Peoria", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 40.69365, "lon": -89.58899}}, {"facility": "011", "city": "Springfield", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 39.80172, "lon": -89.64371}}, {"facility": "078", "city": "Indianapolis", "state": "Indiana", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "073", "city": "Ames", "state": "Iowa", "country": "United States", "geoPoint": {"lat": 42.03471, "lon": -93.61994}}, {"facility": "124", "city": "Manhattan", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 39.18361, "lon": -96.57167}}, {"facility": "023", "city": "Wichita", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 37.69224, "lon": -97.33754}}, {"facility": "160", "city": "Wichita", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 37.69224, "lon": -97.33754}}, {"facility": "164", "city": "Lexington", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "062", "city": "Louisville", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"facility": "029", "city": "Scarborough", "state": "Maine", "country": "United States", "geoPoint": {"lat": 43.57814, "lon": -70.32172}}, {"facility": "020", "city": "Baltimore", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "034", "city": "Baltimore", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "065", "city": "Pikesville", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.37427, "lon": -76.72247}}, {"facility": "137", "city": "Waldorf", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.62456, "lon": -76.93914}}, {"facility": "041", "city": "Detroit", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "030", "city": "Golden Valley", "state": "Minnesota", "country": "United States", "geoPoint": {"lat": 45.00969, "lon": -93.34912}}, {"facility": "071", "city": "Hattiesburg", "state": "Mississippi", "country": "United States", "geoPoint": {"lat": 31.32712, "lon": -89.29034}}, {"facility": "031", "city": "Chesterfield", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.66311, "lon": -90.57707}}, {"facility": "066", "city": "Saint Louis", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "017", "city": "Lebanon", "state": "New Hampshire", "country": "United States", "geoPoint": {"lat": 43.64229, "lon": -72.25176}}, {"facility": "067", "city": "Voorhees", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 40.48122, "lon": -74.48321}}, {"facility": "036", "city": "Albany", "state": "New York", "country": "United States", "geoPoint": {"lat": 42.65258, "lon": -73.75623}}, {"facility": "083", "city": "Buffalo", "state": "New York", "country": "United States", "geoPoint": {"lat": 42.88645, "lon": -78.87837}}, {"facility": "069", "city": "Cedarhurst", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.62288, "lon": -73.7243}}, {"facility": "027", "city": "New York", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "122", "city": "New York", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "003", "city": "Asheville", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.60095, "lon": -82.55402}}, {"facility": "063", "city": "Durham", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "117", "city": "Wilmington", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 34.22573, "lon": -77.94471}}, {"facility": "015", "city": "Cleveland", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "061", "city": "Columbus", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "002", "city": "Toledo", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.66394, "lon": -83.55521}}, {"facility": "147", "city": "Oklahoma City", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "100", "city": "Greensburg", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.30146, "lon": -79.53893}}, {"facility": "032", "city": "Philadelphia", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "024", "city": "Beaufort", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 32.43158, "lon": -80.66983}}, {"facility": "114", "city": "Chattanooga", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 35.04563, "lon": -85.30968}}, {"facility": "001", "city": "Nashville", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "138", "city": "Austin", "state": "Texas", "country": "United States", "geoPoint": {"lat": 30.26715, "lon": -97.74306}}, {"facility": "022", "city": "Dallas", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "046", "city": "El Paso", "state": "Texas", "country": "United States", "geoPoint": {"lat": 31.75872, "lon": -106.48693}}, {"facility": "051", "city": "Houston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "053", "city": "Houston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "098", "city": "San Antonio", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "136", "city": "Layton", "state": "Utah", "country": "United States", "geoPoint": {"lat": 41.06022, "lon": -111.97105}}, {"facility": "161", "city": "Alexandria", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 38.80484, "lon": -77.04692}}, {"facility": "016", "city": "Charlottesville", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 38.02931, "lon": -78.47668}}, {"facility": "074", "city": "Renton", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.48288, "lon": -122.21707}}, {"facility": "080", "city": "Madison", "state": "Wisconsin", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}, {"facility": "421", "city": "Capmerdown", "state": "New South Wales", "country": "Australia"}, {"facility": "425", "city": "Chatswood", "state": "New South Wales", "country": "Australia", "geoPoint": {"lat": -33.8, "lon": 151.18333}}, {"facility": "423", "city": "Herston", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.44453, "lon": 153.01852}}, {"facility": "420", "city": "Adelaide", "state": "South Australia", "country": "Australia", "geoPoint": {"lat": -34.92866, "lon": 138.59863}}, {"facility": "427", "city": "Parkville", "state": "Victoria", "country": "Australia", "geoPoint": {"lat": -37.78333, "lon": 144.95}}, {"facility": "140", "city": "Halifax", "state": "Nova Scotia", "country": "Canada", "geoPoint": {"lat": 44.64533, "lon": -63.57239}}, {"facility": "116", "city": "Hamilton", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 43.25011, "lon": -79.84963}}, {"facility": "093", "city": "London", "state": "Ontario", "country": "Canada", "geoPoint": {"lat": 42.98339, "lon": -81.23304}}, {"facility": "091", "city": "Greenfield Park", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.48649, "lon": -73.46223}}, {"facility": "110", "city": "Montreal", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "113", "city": "Montreal", "state": "Quebec", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "127", "city": "Calgary", "country": "Canada", "geoPoint": {"lat": 51.05011, "lon": -114.08529}}, {"facility": "223", "city": "Aarhus", "country": "Denmark", "geoPoint": {"lat": 56.15674, "lon": 10.21076}}, {"facility": "461", "city": "Mainz", "country": "Germany", "geoPoint": {"lat": 49.98419, "lon": 8.2791}}, {"facility": "443", "city": "Ferrara", "country": "Italy", "geoPoint": {"lat": 44.83804, "lon": 11.62057}}, {"facility": "445", "city": "Reggio Calabria", "country": "Italy", "geoPoint": {"lat": 38.11047, "lon": 15.66129}}, {"facility": "447", "city": "Torrette Di Ancona", "country": "Italy"}, {"facility": "284", "city": "Czestochowa", "country": "Poland", "geoPoint": {"lat": 50.79646, "lon": 19.12409}}, {"facility": "286", "city": "Gdansk", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"facility": "282", "city": "Gdynia", "country": "Poland", "geoPoint": {"lat": 54.51889, "lon": 18.53188}}, {"facility": "280", "city": "Krakow", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "290", "city": "Lublin", "country": "Poland", "geoPoint": {"lat": 51.25, "lon": 22.56667}}, {"facility": "289", "city": "Szczecin", "country": "Poland", "geoPoint": {"lat": 53.42894, "lon": 14.55302}}, {"facility": "281", "city": "Warszawa", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "287", "city": "Warszawa", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "324", "city": "Santa Cruz de Tenerife", "country": "Spain", "geoPoint": {"lat": 28.46824, "lon": -16.25462}}, {"facility": "360", "city": "Blackpool", "country": "United Kingdom", "geoPoint": {"lat": 53.81667, "lon": -3.05}}, {"facility": "367", "city": "Cornwall", "country": "United Kingdom"}, {"facility": "364", "city": "London", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "369", "city": "London", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "363", "city": "Middlesborough", "country": "United Kingdom", "geoPoint": {"lat": 54.57623, "lon": -1.23483}}]}, "referencesModule": {"seeAlsoLinks": [{"label": "FDA Safety Alerts and Recalls", "url": "http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Participant Flow refers to the Safety Set, which is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.", "recruitmentDetails": "This Multicenter, Open-Label Study started to enroll Subjects in February 2008.", "groups": [{"id": "FG000", "title": "Lacosamide", "description": "Lacosamide tablets for dosing 100 -800 mg/day"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "322"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "210"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "112"}]}], "dropWithdraws": [{"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "30"}]}, {"type": "Fatal Serious AE", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}, {"type": "Non Fatal Serious AE", "reasons": [{"groupId": "FG000", "numSubjects": "7"}]}, {"type": "Non Fatal Non Serious AE", "reasons": [{"groupId": "FG000", "numSubjects": "12"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "3"}]}, {"type": "Unsatisfactory compliance of subject", "reasons": [{"groupId": "FG000", "numSubjects": "11"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "9"}]}, {"type": "Other reason for premature termination", "reasons": [{"groupId": "FG000", "numSubjects": "17"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Baseline Characteristics refer to the Safety Set, which is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.", "groups": [{"id": "BG000", "title": "Lacosamide", "description": "Lacosamide tablets for dosing 100 -800 mg/day"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "322"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "8"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "301"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "13"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"title": "mean (standard deviation)", "categories": [{"measurements": [{"groupId": "BG000", "value": "40.7", "spread": "13.3"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "161"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "161"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "258"}]}]}, {"title": "Black or African American", "categories": [{"measurements": [{"groupId": "BG000", "value": "46"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "17"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Percentage of Subjects on Lacosamide (LCM) Monotherapy at Any Time Between Visit 1 and End of Study", "description": "Percentage of Subjects on Lacosamide (LCM) Monotherapy at any time between Visit 1 and End of Study.", "populationDescription": "All 322 Subjects from the Safety Set are included in the Analysis of this Outcome Measure. Safety Set is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)", "groups": [{"id": "OG000", "title": "Lacosamide", "description": "Lacosamide tablets for dosing 100 -800 mg/day"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "322"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "292"}]}]}]}, {"type": "PRIMARY", "title": "Duration of Lacosamide (LCM) Monotherapy Treatment From Visit 1 to End of Study", "description": "Duration of total Lacosamide Monotherapy From Visit 1 to End of Study.", "populationDescription": "All 322 Subjects from the Safety Set are included in the Analysis of this Outcome Measure. Safety Set is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "days", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)", "groups": [{"id": "OG000", "title": "Lacosamide", "description": "Lacosamide tablets for dosing 100 -800 mg/day"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "322"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "479.1", "spread": "271.9"}]}]}]}, {"type": "SECONDARY", "title": "Occurrence of At Least One Treatment-Emergent Adverse Event (TEAE) From Visit 1 to End of Study", "description": "A TEAE is defined as any untoward medical occurrence (eg, noxious or pathological changes) in a subject or clinical investigation subject compared with pre-existing conditions, that occurs during any phase of a clinical trial including Pretreatment, Run-In, Wash-Out, or Follow-Up Phases.\n\nAn TEAE is defined as being independent of assumption of any causality (eg, to trial or concomitant medication, primary or concomitant disease, or trial design).", "populationDescription": "All 322 Subjects from the Safety Set are included in the Analysis of this Outcome Measure. Safety Set is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)", "groups": [{"id": "OG000", "title": "Lacosamide", "description": "Lacosamide tablets for dosing 100 -800 mg/day"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "322"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "296"}]}]}]}, {"type": "SECONDARY", "title": "Occurrence of Treatment-Emergent Adverse Events (TEAE) Leading to Subject Withdrawal From Visit 1 to End of Study", "populationDescription": "All 322 Subjects from the Safety Set are included in the Analysis of this Outcome Measure. Safety Set is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Visit 1 to End of Study (approximately 2 years)", "groups": [{"id": "OG000", "title": "Lacosamide", "description": "Lacosamide tablets for dosing 100 -800 mg/day"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "322"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "22"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Adverse Events were collected from Study Start (Visit 1) until the End of Study (up to 2 years).", "description": "Adverse Events refer to the Safety Set, which is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.", "eventGroups": [{"id": "EG000", "title": "Lacosamide", "description": "Lacosamide tablets for dosing 100 -800 mg/day", "seriousNumAffected": 56, "seriousNumAtRisk": 322, "otherNumAffected": 238, "otherNumAtRisk": 322}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Congestive cardiomyopathy", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Cardiac tamponade", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Vision blurred", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Intestinal obstruction", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Melaena", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Sudden unexplained death in epilepsy", "organSystem": "General disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Bacteraemia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Tubo-ovarian abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 322}]}, {"term": "Cervical vertebral fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Concussion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Foot fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Laceration", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Pulmonary contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Road traffic accident", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Ankle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Head injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Post procedural haemorrhage", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Tendon rupture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Toxicity to various agents", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Electroencephalogram", "organSystem": "Investigations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Heart rate decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Intervertebral disc disorder", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Rotator cuff syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Breast cancer stage II", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Cervix carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Colon neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Metastatic squamous cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Convulsion", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 19, "numAffected": 17, "numAtRisk": 322}]}, {"term": "Status epilepticus", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 4, "numAtRisk": 322}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 322}]}, {"term": "Postictal state", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 322}]}, {"term": "Complicated migraine", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Depressed level of consciousness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Hydrocephalus", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Transient ischaemic attack", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Brain oedema", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Dyskinesia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Grand mal convulsion", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Migraine", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Acute psychosis", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Confusional state", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Delirium", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Suicidal ideation", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Postictal psychosis", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Nephrolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Seborrhoeic dermatitis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 322}]}], "otherEvents": [{"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 68, "numAffected": 46, "numAtRisk": 322}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 37, "numAffected": 27, "numAtRisk": 322}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 27, "numAffected": 23, "numAtRisk": 322}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 44, "numAffected": 40, "numAtRisk": 322}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 53, "numAffected": 45, "numAtRisk": 322}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 53, "numAffected": 38, "numAtRisk": 322}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 30, "numAffected": 20, "numAtRisk": 322}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 23, "numAffected": 19, "numAtRisk": 322}]}, {"term": "Fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 44, "numAffected": 31, "numAtRisk": 322}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 49, "numAffected": 25, "numAtRisk": 322}]}, {"term": "Laceration", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 32, "numAffected": 22, "numAtRisk": 322}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 41, "numAffected": 31, "numAtRisk": 322}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 17, "numAtRisk": 322}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 142, "numAffected": 89, "numAtRisk": 322}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 81, "numAffected": 55, "numAtRisk": 322}]}, {"term": "Convulsion", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 42, "numAffected": 29, "numAtRisk": 322}]}, {"term": "Tremor", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 30, "numAffected": 26, "numAtRisk": 322}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 26, "numAffected": 24, "numAtRisk": 322}]}, {"term": "Insomnia", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 24, "numAffected": 20, "numAtRisk": 322}]}, {"term": "Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 21, "numAffected": 17, "numAtRisk": 322}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA16.1", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 31, "numAffected": 20, "numAtRisk": 322}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "GT60", "restrictiveAgreement": true}, "pointOfContact": {"title": "UCB Clinical Trial Call Center", "organization": "UCB Pharma", "phone": "+1 877 822 9493"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000004827", "term": "Epilepsy"}, {"id": "D000012640", "term": "Seizures"}], "ancestors": [{"id": "D000001927", "term": "Brain Diseases"}, {"id": "D000002493", "term": "Central Nervous System Diseases"}, {"id": "D000009422", "term": "Nervous System Diseases"}, {"id": "D000009461", "term": "Neurologic Manifestations"}], "browseLeaves": [{"id": "M7983", "name": "Epilepsy", "asFound": "Epilepsy", "relevance": "HIGH"}, {"id": "M15452", "name": "Seizures", "asFound": "Seizures", "relevance": "HIGH"}, {"id": "M5204", "name": "Brain Diseases", "relevance": "LOW"}, {"id": "M5742", "name": "Central Nervous System Diseases", "relevance": "LOW"}, {"id": "M12404", "name": "Neurologic Manifestations", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC10", "name": "Nervous System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000078334", "term": "Lacosamide"}], "ancestors": [{"id": "D000000927", "term": "Anticonvulsants"}, {"id": "D000061567", "term": "Voltage-Gated Sodium Channel Blockers"}, {"id": "D000026941", "term": "Sodium Channel Blockers"}, {"id": "D000049990", "term": "Membrane Transport Modulators"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M1961", "name": "Lacosamide", "asFound": "Phase 3 Study", "relevance": "HIGH"}, {"id": "M4246", "name": "Anticonvulsants", "relevance": "LOW"}, {"id": "M23177", "name": "Sodium Channel Blockers", "relevance": "LOW"}, {"id": "M30025", "name": "Diuretics, Potassium Sparing", "relevance": "LOW"}], "browseBranches": [{"abbrev": "ChanBlk", "name": "Channel Blockers"}, {"abbrev": "AntiConv", "name": "Anticonvulsants"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}